Biological effects of probiotics
The medical advantages from probiotic items and applications are to a great degree differing and are persistently extended with new experiences and logical advancements. Probiotic microorganisms can be utilized to enhance or re-establish microbial homeostasis in two situations. Firstly, they may involve utilitarian specialties that are left open by the endogenous group, in this manner counteracting pathogens from involving that specialty. Such process is frequently alluded to as focused rejection, and essentially focuses on the opposition for supplements, physical methods or receptors. The second situation is a greater amount of an adversarial nature as probiotics may effectively lower pathogen intrusion or advancement into the biological community. Such approach essentially targets: i) the creation of short chain unsaturated fats and other natural acids (e.g. lactic acid) by probiotics, subsequently bringing down the pH and expanding the bacteriostatic impact of natural acids towards pathogens; ii) the creation of bacteriocins, which are little microbial peptides with bacteriostatic or, then again bactericidal action; and iii) the generation of responsive oxygen species, for example, hydrogen peroxide, that are exceedingly receptive and increment oxidative worry for pathogens in miniaturized scale situations.
Related Conference of Biological effects of probiotics
October 27-28, 2026
14th International Conference on COPD Clinical Trials & Lung Care Advances
Paris, France
November 19-20, 2026
18th International Conference on Chronic Obstructive Pulmonary Disease
Dubai, UAE
November 23-24, 2026
16th International Conference on Pulmonary & Respiratory Medicine
Paris, France
January 27-28, 2027
7th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Biological effects of probiotics Conference Speakers
Recommended Sessions
- Prebiotic Foods
- Applications of probiotics in Aquaculture
- Applications of Probiotics in Health and Diseases
- Biological effects of probiotics
- Common Therapies of Probiotics
- Genomics of Probiotics and Prebiotics
- Health Effects and Applications of Prebiotics
- Mechanisms of Probiotics
- Microbiome and Probiotics
- Prebiotics
- Probiotic Industrial Products
- Probiotic Nutrition
- Probiotics
- Probiotics for Animal Health
- Regulatory perspectives of Probiotics and Prebiotics
- Strains of Probiotics
- Synbiotic
- The Future of Prebiotics and Probiotics
Related Journals
Are you interested in
- Active TB Case Finding in Underserved Settings - Tuberculosis-2027 (France)
- Acute Exacerbations and Intensive Care - COPD_2026 (UAE)
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- Advances in COPD Pharmacotherapy - COPD_2026 (UAE)
- Advancing Equity in Global TB Control - Tuberculosis-2027 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- Anatomical and Surgical Pathology - PATHOLOGY MEET 2027 (France)
- Artificial Intelligence & Digital Health in Respiratory Medicine - COPD SUMMIT 2026 (Italy)
- Asthama - Copd 2026 (France)
- Asthma & Airway Diseases - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Building Trust in TB Services Through Local Partnerships - Tuberculosis-2027 (France)
- Cancer Pathology and Biomarker Research - PATHOLOGY MEET 2027 (France)
- Challenges in TB Diagnosis Among Vulnerable Populations - Tuberculosis-2027 (France)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- Clinical Biochemistry and Laboratory Diagnostics - PATHOLOGY MEET 2027 (France)
- Clinical Pathology and Laboratory Medicine - PATHOLOGY MEET 2027 (France)
- Clinical Research and Translational Medicine - COPD_2026 (UAE)
- Community-Based TB Outreach for Hard-to-Reach Populations - Tuberculosis-2027 (France)
- COPD - COPD SUMMIT 2026 (Italy)
- COPD Comorbidities and Multidisciplinary Care - COPD_2026 (UAE)
- COPD Epidemiology and Public Health - COPD_2026 (UAE)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis and Molecular Mechanisms - COPD_2026 (UAE)
- COPD Phenotypes and Precision Medicine - COPD_2026 (UAE)
- COPD: Emerging Therapies & Disease Management - COPD SUMMIT 2026 (Italy)
- COPD: Prevention, Diagnosis & Management - COPD SUMMIT 2026 (Italy)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Critical Care Pulmonology & Mechanical Ventilation - COPD SUMMIT 2026 (Italy)
- Cross-Border TB Care for Migrant Health - Tuberculosis-2027 (France)
- Current Research & Innovations in Pulmonology - COPD SUMMIT 2026 (Italy)
- Cystic Fibrosis - Copd 2026 (France)
- Designing Equitable TB Services for Homeless and Marginalized Groups - Tuberculosis-2027 (France)
- Digital Health, Telemedicine and Artificial Intelligence in COPD - COPD_2026 (UAE)
- Digital Pathology and Artificial Intelligence - PATHOLOGY MEET 2027 (France)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Digital Tools for TB Outreach and Follow-Up - Tuberculosis-2027 (France)
- Early Diagnosis, Screening and Biomarkers - COPD_2026 (UAE)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Environmental Pollution and Occupational Lung Diseases - COPD_2026 (UAE)
- Equitable TB Treatment for Displaced Communities - Tuberculosis-2027 (France)
- Future Directions in COPD & Lung Diseases - COPD SUMMIT 2026 (Italy)
- Future Innovations in COPD and Respiratory Healthcare - COPD_2026 (UAE)
- General Pathology and Disease Mechanisms - PATHOLOGY MEET 2027 (France)
- Health Literacy and TB Awareness in Vulnerable Communities - Tuberculosis-2027 (France)
- Hematopathology and Transfusion Medicine - PATHOLOGY MEET 2027 (France)
- Histopathology and Cytopathology Innovations - PATHOLOGY MEET 2027 (France)
- Immunopathology and Autoimmune Disorders - PATHOLOGY MEET 2027 (France)
- Improving TB Treatment Adherence in Mobile Populations - Tuberculosis-2027 (France)
- Innovative Outreach Models for TB Case Detection Among Migrants - Tuberculosis-2027 (France)
- Integrated TB and Social Support Services - Tuberculosis-2027 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases (ILD) - COPD SUMMIT 2026 (Italy)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Laboratory Automation, Robotics and Smart Labs - PATHOLOGY MEET 2027 (France)
- Laboratory Quality Management and Accreditation - PATHOLOGY MEET 2027 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer & Thoracic Oncology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Diseases - COPD SUMMIT 2026 (Italy)
- Lung Imaging and Pulmonary Function Technologies - COPD_2026 (UAE)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Microbiology and Infectious Disease Pathology - PATHOLOGY MEET 2027 (France)
- Molecular Pathology and Genomic Medicine - PATHOLOGY MEET 2027 (France)
- Occupational & Environmental Lung Diseases - COPD SUMMIT 2026 (Italy)
- Patient-Centered TB Services for Marginalized Groups - Tuberculosis-2027 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pediatric Pulmonology - COPD SUMMIT 2026 (Italy)
- Pneumonia - Copd 2026 (France)
- Pneumonia - COPD SUMMIT 2026 (Italy)
- Point-of-Care Testing and Rapid Diagnostics - PATHOLOGY MEET 2027 (France)
- Precision Medicine and Personalized Diagnostics - PATHOLOGY MEET 2027 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis - COPD SUMMIT 2026 (Italy)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation & Respiratory Care - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation and Chronic Care - COPD_2026 (UAE)
- Reducing TB Stigma Through Community Engagement - Tuberculosis-2027 (France)
- Respiratory Diagnostics & Lung Function Testing - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections and Lung Microbiome - COPD_2026 (UAE)
- Respiratory Medicine and Pulmonology - COPD_2026 (UAE)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Medicine & Sleep-Related Breathing Disorders - COPD SUMMIT 2026 (Italy)
- Social Determinants of TB in Vulnerable Populations - Tuberculosis-2027 (France)
- Social Support as a Strategy for Improving TB Outcomes - Tuberculosis-2027 (France)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- TB Care Among Migrants and Refugees: Barriers and Solutions - Tuberculosis-2027 (France)
- TB Care Continuity for Displaced and Mobile Populations - Tuberculosis-2027 (France)
- TB Control in Homeless Shelters and Temporary Housing - Tuberculosis-2027 (France)
- TB Prevention Among Socially Excluded Groups - Tuberculosis-2027 (France)
- TB Screening Strategies for Refugee Communities - Tuberculosis-2027 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
- Tuberculosis - COPD SUMMIT 2026 (Italy)
- Tuberculosis in Homeless Populations: Improving Early Detection - Tuberculosis-2027 (France)
- Tuberculosis in Vulnerable Populations: Closing Gaps in Access to Care - Tuberculosis-2027 (France)
